The PCAST Report: Impact and Implications for the Pharmaceutical Industry

The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefi...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2013-09, Vol.94 (3), p.300-302
Main Authors: Morris, S A, Rosenblatt, M, Orloff, J J, Lewis-Hall, F, Waldstreicher, J
Format: Article
Language:English
Subjects:
Biopharmaceutics
Drug Discovery
Drug Industry
Federal Government
Government Regulation
Inventions
Public-Private Sector Partnerships
Translational Medical Research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3
cites cdi_FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3
container_end_page 302
container_issue 3
container_start_page 300
container_title Clinical pharmacology and therapeutics
container_volume 94
creator Morris, S A
Rosenblatt, M
Orloff, J J
Lewis-Hall, F
Waldstreicher, J
description The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefit to society. Clear leadership, commitment to action, and unprecedented collaboration will be essential if the goal of the report is to be realized. Clinical Pharmacology & Therapeutics (2013); 94 3, 300–302. doi:10.1038/clpt.2013.93
doi_str_mv 10.1038/clpt.2013.93
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1427007461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1427007461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3</originalsourceid><addsrcrecordid>eNp9kDtP7DAQRi0EguXRUaOUtyCL7Umc-HYo4rGrFawgQGk5tiMCySbYjmD_PQkLlFQzoznfVxyEjgmeEgzpmao7P6WYwJTDFpqQGGjIYoi30QRjzENOge2hfedehjPiabqL9ihwBpSwCZrlzyZYZuf3eXBnutb6_8Gs6aTygVzpca0rJX3VrlxQtjbwI_0sbSOV6f3wqoPZSvfO2_Uh2ill7czR9zxAD5cXeXYdLm6vZtn5IlSQJBBGqS5NpGgMhMoilRpTFmklyxSAFZjTgiqsGWBWkDhKQBEOTCvKoVAx0yUcoH-b3s62b71xXjSVU6au5cq0vRMkognGScTIgJ5uUGVb56wpRWerRtq1IFiM8sQoT4zyBIcBP_lu7ovG6F_4x9YAJBvgvarN-s8ykS3zbLHMx_OrOtwkK-fNx29S2lfBEkhi8XRzJeaP2fxpfn0pCHwCSH6J1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1427007461</pqid></control><display><type>article</type><title>The PCAST Report: Impact and Implications for the Pharmaceutical Industry</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Morris, S A ; Rosenblatt, M ; Orloff, J J ; Lewis-Hall, F ; Waldstreicher, J</creator><creatorcontrib>Morris, S A ; Rosenblatt, M ; Orloff, J J ; Lewis-Hall, F ; Waldstreicher, J</creatorcontrib><description>The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefit to society. Clear leadership, commitment to action, and unprecedented collaboration will be essential if the goal of the report is to be realized. Clinical Pharmacology &amp; Therapeutics (2013); 94 3, 300–302. doi:10.1038/clpt.2013.93</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2013.93</identifier><identifier>PMID: 23963216</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Biopharmaceutics ; Drug Discovery ; Drug Industry ; Federal Government ; Government Regulation ; Inventions ; Public-Private Sector Partnerships ; Translational Medical Research</subject><ispartof>Clinical pharmacology and therapeutics, 2013-09, Vol.94 (3), p.300-302</ispartof><rights>2013 American Society for Clinical Pharmacology and Therapeutics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3</citedby><cites>FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23963216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morris, S A</creatorcontrib><creatorcontrib>Rosenblatt, M</creatorcontrib><creatorcontrib>Orloff, J J</creatorcontrib><creatorcontrib>Lewis-Hall, F</creatorcontrib><creatorcontrib>Waldstreicher, J</creatorcontrib><title>The PCAST Report: Impact and Implications for the Pharmaceutical Industry</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clinical Pharmacology &amp; Therapeutics</addtitle><description>The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefit to society. Clear leadership, commitment to action, and unprecedented collaboration will be essential if the goal of the report is to be realized. Clinical Pharmacology &amp; Therapeutics (2013); 94 3, 300–302. doi:10.1038/clpt.2013.93</description><subject>Biopharmaceutics</subject><subject>Drug Discovery</subject><subject>Drug Industry</subject><subject>Federal Government</subject><subject>Government Regulation</subject><subject>Inventions</subject><subject>Public-Private Sector Partnerships</subject><subject>Translational Medical Research</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kDtP7DAQRi0EguXRUaOUtyCL7Umc-HYo4rGrFawgQGk5tiMCySbYjmD_PQkLlFQzoznfVxyEjgmeEgzpmao7P6WYwJTDFpqQGGjIYoi30QRjzENOge2hfedehjPiabqL9ihwBpSwCZrlzyZYZuf3eXBnutb6_8Gs6aTygVzpca0rJX3VrlxQtjbwI_0sbSOV6f3wqoPZSvfO2_Uh2ill7czR9zxAD5cXeXYdLm6vZtn5IlSQJBBGqS5NpGgMhMoilRpTFmklyxSAFZjTgiqsGWBWkDhKQBEOTCvKoVAx0yUcoH-b3s62b71xXjSVU6au5cq0vRMkognGScTIgJ5uUGVb56wpRWerRtq1IFiM8sQoT4zyBIcBP_lu7ovG6F_4x9YAJBvgvarN-s8ykS3zbLHMx_OrOtwkK-fNx29S2lfBEkhi8XRzJeaP2fxpfn0pCHwCSH6J1A</recordid><startdate>201309</startdate><enddate>201309</enddate><creator>Morris, S A</creator><creator>Rosenblatt, M</creator><creator>Orloff, J J</creator><creator>Lewis-Hall, F</creator><creator>Waldstreicher, J</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201309</creationdate><title>The PCAST Report: Impact and Implications for the Pharmaceutical Industry</title><author>Morris, S A ; Rosenblatt, M ; Orloff, J J ; Lewis-Hall, F ; Waldstreicher, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biopharmaceutics</topic><topic>Drug Discovery</topic><topic>Drug Industry</topic><topic>Federal Government</topic><topic>Government Regulation</topic><topic>Inventions</topic><topic>Public-Private Sector Partnerships</topic><topic>Translational Medical Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morris, S A</creatorcontrib><creatorcontrib>Rosenblatt, M</creatorcontrib><creatorcontrib>Orloff, J J</creatorcontrib><creatorcontrib>Lewis-Hall, F</creatorcontrib><creatorcontrib>Waldstreicher, J</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morris, S A</au><au>Rosenblatt, M</au><au>Orloff, J J</au><au>Lewis-Hall, F</au><au>Waldstreicher, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PCAST Report: Impact and Implications for the Pharmaceutical Industry</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clinical Pharmacology &amp; Therapeutics</addtitle><date>2013-09</date><risdate>2013</risdate><volume>94</volume><issue>3</issue><spage>300</spage><epage>302</epage><pages>300-302</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><abstract>The President's Council of Advisors on Science and Technology (PCAST) report sets out an ambitious goal: to double the output of innovative, new medicines with increased efficacy and safety within the next 10–15 years. If attainable, this could change the face of medicine and bring great benefit to society. Clear leadership, commitment to action, and unprecedented collaboration will be essential if the goal of the report is to be realized. Clinical Pharmacology &amp; Therapeutics (2013); 94 3, 300–302. doi:10.1038/clpt.2013.93</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23963216</pmid><doi>10.1038/clpt.2013.93</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2013-09, Vol.94 (3), p.300-302
issn 0009-9236
1532-6535
language eng
recordid cdi_proquest_miscellaneous_1427007461
source Wiley-Blackwell Read & Publish Collection
subjects Biopharmaceutics
Drug Discovery
Drug Industry
Federal Government
Government Regulation
Inventions
Public-Private Sector Partnerships
Translational Medical Research
title The PCAST Report: Impact and Implications for the Pharmaceutical Industry
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A59%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PCAST%20Report:%20Impact%20and%20Implications%20for%20the%20Pharmaceutical%20Industry&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Morris,%20S%20A&rft.date=2013-09&rft.volume=94&rft.issue=3&rft.spage=300&rft.epage=302&rft.pages=300-302&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1038/clpt.2013.93&rft_dat=%3Cproquest_cross%3E1427007461%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3773-48dfe4c25312ab8ad0264dcaf8336b092b2c0d6306b15473c1936dc293bc56df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1427007461&rft_id=info:pmid/23963216&rfr_iscdi=true